IBM, US4592001014

UBS keeps USD 236 target for IBM stock below its 52-week high

Published on 10/16/2026 at 10:42 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

UBS keeps a USD 236.00 target for IBM on October 13, 2026. IBM stock costs EUR 208.60 versus the EUR 207.95 Xetra close.

Analyst view and reporting date

UBS maintained a USD 236.00 price target and Neutral rating on October 13, 2026.
IBM reported USD 17.16 billion in second-quarter 2026 revenue, up 1.10 percent year over year.
IBM stock trades at EUR 208.60 at 10:37 a.m. CEST at Lang & Schwarz on October 16, 2026, plus 0.31 percent above the Xetra close of October 15, 2026.

Editorial stock trading floor photograph with large wall-mounted monitors displaying sector labels ENTERPRISE IT, CLOUD, QUANTUM, and NYSE in bold white text on dark screens, with financial line charts and data grids below, traders seated at workstations — IBM Börsensaal Monitore zeigen ENTERPRISE IT CLOUD QUANTUM NYSE und neutrale Charts US4592001014, Illustration mit AI erstellt.

IBM (ISIN US4592001014) stock was trading at EUR 208.60 at Lang & Schwarz on October 16, 2026 at 10:37 a.m. CEST, up 0.31 percent versus the Xetra close of October 15, 2026 at EUR 207.95. The latest analyst signal came from Investing.com, which reported on October 13, 2026 that UBS maintained a Neutral rating and a USD 236.00 price target.

UBS flags delayed deal recovery

UBS said IBM had recaptured less than 50 percent of deals that slipped out of the second quarter. The firm also cited supply constraints across servers, storage and memory, while placing its calendar third-quarter revenue forecast at USD 16.678 billion, below the USD 16.798 billion Visible Alpha consensus reported in the same October 13 article.

The target sits above the October 16 euro quotation in a different currency, so the comparison is not converted into a euro-based target distance. IBM's market capitalization was USD 220.6 billion as of October 16, 2026, while its USD 52-week range was USD 199.19 to USD 332.46.

What does the next report test?

IBM's second-quarter 2026 revenue reached USD 17.16 billion, up 1.10 percent from USD 16.98 billion in the second quarter of 2025, according to Financial Report Insights. The report also said IBM reduced its full-year constant-currency revenue growth outlook to 4 percent to 5 percent from more than 5 percent.

Three recent IBM milestones

On October 7, 2026, Yorkville Ives initiated coverage with an Outperform rating and a USD 275.00 target, according to Investing.com. On October 9, 2026, Truist Securities began coverage at Hold with a USD 240.00 target, as Yahoo Finance reported. On October 13, 2026, UBS maintained its USD 236.00 target.

Next date is October 21

IBM will discuss third-quarter 2026 results on October 21, 2026 at 5:00 p.m. ET, according to the IBM newsroom. The appointment gives investors a defined checkpoint for deferred deals, software growth and the reduced outlook.

IBM stock remains below its yearly high

IBM's USD 332.46 52-week high leaves the stock 28.72 percent below that level based on the October 16, 2026 euro quotation. The immediate market question is whether the October 21 report can clarify the timing of delayed contracts.

IBM was trading at EUR 208.60 at Lang & Schwarz on October 16, 2026 at 10:37 a.m. CEST, plus 0.31 percent versus the Xetra close of October 15, 2026 at EUR 207.95. The further course of trading is shown by the continuously updated real-time quote of IBM stock.